Angga Cipta Narsa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Angga Cipta Narsa has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Nasrul Wathoni
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia
7 shared publications - Hadi Kuncoro
Universitas Mulawarman, Indonesia
4 shared publications Ahmed Fouad Abdelwahab Mohammed
Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt
3 shared publications- Fajar Prasetya
Department of Pharmacology, Faculty of Pharmacy, Mulawarman University, Samarinda, East Borneo, Indonesia
3 shared publications - Gofarana Wilar
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia
3 shared publications Ali El-Rayyes
Department of Chemistry, College of Science, Northern Border University, Arar, Saudi Arabia
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Universitas Mulawarman in Jurnal Sains dan Kesehatan
- Vol. 7 (3) , 52-60
Effect of PVP K-30 Polymer Variation on Particle Size and Characteristics of Kratom Leaf Extract (Mitragyna speciosa K.) Nanosuspension
Kratom (Mitragyna speciosa K.) possesses therapeutic potential that is limited by its poor aqueous solubility. This study aimed to analyze the effect of varying polyvinylpyrrolidone (PVP K-30) concentrations as a steric stabilizer on the physicochemical parameters, morphology, and in vitro dissolution profile of kratom leaf ethanol extract nanosuspension. Formulations were prepared via the nanoprecipitation technique with extract-to-PVP K-30 mass ratios of 1:0 (F0), 1:1 (F1), 1:2 (F2), and 1:4 (F3). Results indicated that the extract (19.02% yield) tested positive for various secondary metabolites. Optical evaluation determined F2 as the most optimal dispersion with a transmittance of 96.76%. The intervention of PVP K-30 in F2 significantly reduced the particle size to 722.9 nm with a homogeneous distribution (PDI 0.685) and yielded a spherical morphology without agglomeration, distinctly different from the F0 control (804.9 nm; PDI 2.095; irregular asymmetric). The 240-minute in vitro dissolution test demonstrated that F2 released 47.15% of active alkaloids, higher than F0 (28.72%). In conclusion, PVP K-30 at a 1:2 ratio proved effective in modifying morphology, suppressing agglomeration, and significantly enhancing the dissolution rate of the preparation.
- 30 September 2026
- Published by Universitas Mulawarman in Jurnal Sains dan Kesehatan
- Vol. 7 (3) , 52-60
Open AccessEffect of PVP K-30 Polymer Variation on Particle Size and Characteristics of Kratom Leaf Extract (Mitragyna speciosa K.) Nanosuspension
Kratom (Mitragyna speciosa K.) possesses therapeutic potential that is limited by its poor aqueous solubility. This study aimed to analyze the effect of varying polyvinylpyrrolidone (PVP K-30) concentrations as a steric stabilizer on the physicochemical parameters, morphology, and in vitro dissolution profile of kratom leaf ethanol extract nanosuspension. Formulations were prepared via the nanoprecipitation technique with extract-to-PVP K-30 mass ratios of 1:0 (F0), 1:1 (F1), 1:2 (F2), and 1:4 (F3). Results indicated that the extract (19.02% yield) tested positive for various secondary metabolites. Optical evaluation determined F2 as the most optimal dispersion with a transmittance of 96.76%. The intervention of PVP K-30 in F2 significantly reduced the particle size to 722.9 nm with a homogeneous distribution (PDI 0.685) and yielded a spherical morphology without agglomeration, distinctly different from the F0 control (804.9 nm; PDI 2.095; irregular asymmetric). The 240-minute in vitro dissolution test demonstrated that F2 released 47.15% of active alkaloids, higher than F0 (28.72%). In conclusion, PVP K-30 at a 1:2 ratio proved effective in modifying morphology, suppressing agglomeration, and significantly enhancing the dissolution rate of the preparation.
- Open Access
- 17 August 2026
- Published by Wiley in ChemistryOpen
- Vol. 15 (9)
Azide‐PEG‐Folate Functionalized Gadolinium Nanoparticles: A Preliminary Click‐Chemistry Platform for Magnetic Resonance Imaging Contrast
Gadolinium nanoparticles (GdNPs) have been studied extensively due to their lower toxicity and better magnetic resonance imaging (MRI) detection capabilities than Gd‐chelates. Their surfaces are conveniently modified with several molecules to enhance their accumulation in the cancer of interest, thereby enabling more accurate diagnosis and treatment. In this study, hydrothermal GdNPs were functionalized with folic acid (FA) (for active targeting), polyethylene glycol (to improve biocompatibility), and azide molecules (for subsequent click reaction) via a silane ligand exchange conjugation method. Results showed a hydrodynamic diameter of 7.90 nm and a zeta potential of −6.80 mV for Azide‐PEG‐Folate‐modified GdNPs. UV spectra confirmed the presence of FA in NPs at UV absorption of 284 and 353 nm. Typical FTIR spectra also appeared at wavenumbers of 2950 and 2150 cm − 1 , confirming the presence of PEG and azide molecules on modified NPs, respectively. Additionally, modified NPs maintained good stability for up to 3 weeks at 25 and 4 °C. A preliminary click in vitro investigation also showed the NPs’ good viability even after incubation at 132 µg/mL, followed by the click reaction with 300 µg/mL of Holmium(III)‐complexed‐DOTA‐BCN on HeLa cancer cells. This first click‐combination finding serves as a promising candidate for Gd/Ho‐MRI agents, thereby enabling a more accurate diagnosis due to their simultaneous T 1 /T 2 contrast enhancement.
- 17 August 2026
- Published by Wiley in ChemistryOpen
- Vol. 15 (9)
Open AccessAzide‐PEG‐Folate Functionalized Gadolinium Nanoparticles: A Preliminary Click‐Chemistry Platform for Magnetic Resonance Imaging Contrast
Gadolinium nanoparticles (GdNPs) have been studied extensively due to their lower toxicity and better magnetic resonance imaging (MRI) detection capabilities than Gd‐chelates. Their surfaces are conveniently modified with several molecules to enhance their accumulation in the cancer of interest, thereby enabling more accurate diagnosis and treatment. In this study, hydrothermal GdNPs were functionalized with folic acid (FA) (for active targeting), polyethylene glycol (to improve biocompatibility), and azide molecules (for subsequent click reaction) via a silane ligand exchange conjugation method. Results showed a hydrodynamic diameter of 7.90 nm and a zeta potential of −6.80 mV for Azide‐PEG‐Folate‐modified GdNPs. UV spectra confirmed the presence of FA in NPs at UV absorption of 284 and 353 nm. Typical FTIR spectra also appeared at wavenumbers of 2950 and 2150 cm − 1 , confirming the presence of PEG and azide molecules on modified NPs, respectively. Additionally, modified NPs maintained good stability for up to 3 weeks at 25 and 4 °C. A preliminary click in vitro investigation also showed the NPs’ good viability even after incubation at 132 µg/mL, followed by the click reaction with 300 µg/mL of Holmium(III)‐complexed‐DOTA‐BCN on HeLa cancer cells. This first click‐combination finding serves as a promising candidate for Gd/Ho‐MRI agents, thereby enabling a more accurate diagnosis due to their simultaneous T 1 /T 2 contrast enhancement.
- Open Access
- 1 August 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-31
Formulation Attributes and Preclinical Wound Healing Outcomes of Natural Product Based Nanoemulsions: A Systematic Review
This systematic review integrates formulation composition and preparation methods with physicochemical characteristics and preclinical wound healing outcomes of directly applied natural product-based liquid nanoemulsions. PubMed and Scopus were searched through February 14, 2026, and the review was conducted in accordance with the PRISMA 2020 guidelines. The review protocol was registered in PROSPERO (CRD420261447376). Eligible studies directly evaluated liquid nanoemulsions as an intervention in in vitro or preclinical in vivo wound-healing models, without subsequent incorporation into a secondary dosage form, and reported physicochemical and/or wound-healing outcomes. Data were synthesized descriptively and narratively; meta-analysis was not performed because of substantial methodological and outcome heterogeneity. Eighteen studies were included, comprising 15 in vivo and three in vitro studies. Particle size, polydispersity index, and zeta potential were reported in 17, 16, and 14 studies, respectively. The median particle size was 120.10 nm (IQR, 46.68– 212.00), median polydispersity index was 0.234 (IQR, 0.147– 0.360), and signed zeta potential ranged from − 40.20 to +44.40 mV. Physicochemical profiles varied substantially across active-material categories, compositions, concentrations, and preparation methods, and no universal physicochemical profile was consistently associated with biological performance. Most studies have reported improved wound contraction, closure, or wound size reduction relative to untreated or vehicle controls, whereas comparisons with standard treatments were inconsistent. Histopathological and mechanistic findings generally supported the macroscopic outcomes but remained heterogeneous. The risk-of-bias assessments for the 15 animal studies were dominated by unclear judgments, particularly for randomization, allocation concealment, random housing, and random outcome assessment, while blinding remained a major concern. Overall, the evidence suggests preclinical wound healing activity and formulation relevance; however, methodological heterogeneity and uncertainty in internal validity preclude conclusions regarding clinical efficacy, clinical superiority, or translational readiness.
- 1 August 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-31
Open AccessFormulation Attributes and Preclinical Wound Healing Outcomes of Natural Product Based Nanoemulsions: A Systematic Review
This systematic review integrates formulation composition and preparation methods with physicochemical characteristics and preclinical wound healing outcomes of directly applied natural product-based liquid nanoemulsions. PubMed and Scopus were searched through February 14, 2026, and the review was conducted in accordance with the PRISMA 2020 guidelines. The review protocol was registered in PROSPERO (CRD420261447376). Eligible studies directly evaluated liquid nanoemulsions as an intervention in in vitro or preclinical in vivo wound-healing models, without subsequent incorporation into a secondary dosage form, and reported physicochemical and/or wound-healing outcomes. Data were synthesized descriptively and narratively; meta-analysis was not performed because of substantial methodological and outcome heterogeneity. Eighteen studies were included, comprising 15 in vivo and three in vitro studies. Particle size, polydispersity index, and zeta potential were reported in 17, 16, and 14 studies, respectively. The median particle size was 120.10 nm (IQR, 46.68– 212.00), median polydispersity index was 0.234 (IQR, 0.147– 0.360), and signed zeta potential ranged from − 40.20 to +44.40 mV. Physicochemical profiles varied substantially across active-material categories, compositions, concentrations, and preparation methods, and no universal physicochemical profile was consistently associated with biological performance. Most studies have reported improved wound contraction, closure, or wound size reduction relative to untreated or vehicle controls, whereas comparisons with standard treatments were inconsistent. Histopathological and mechanistic findings generally supported the macroscopic outcomes but remained heterogeneous. The risk-of-bias assessments for the 15 animal studies were dominated by unclear judgments, particularly for randomization, allocation concealment, random housing, and random outcome assessment, while blinding remained a major concern. Overall, the evidence suggests preclinical wound healing activity and formulation relevance; however, methodological heterogeneity and uncertainty in internal validity preclude conclusions regarding clinical efficacy, clinical superiority, or translational readiness.
- Open Access
- 14 June 2026
- Published by Brieflands in Iranian Journal of Pharmaceutical Research
- Vol. 25 (1) , e171722
Hepatoprotective Effects of Ethyl Acetate Extract of Lygodium microphyllum Leaves
Background: Lygodium microphyllum is traditionally used in Chinese medicine as a decoction to treat hepatitis. Objectives: This study evaluated the in vivo hepatoprotective efficacy and optimal dose of the ethyl acetate extract of L. microphyllum leaves (EALM) against paracetamol-induced liver injury. Methods: A pilot experiment was conducted in 24 male Wistar rats divided into six groups: a normal control group, a paracetamol control group (3 g/kg body weight [BW]), and three EALM groups (200, 400, and 600 mg/kg BW). EALM was administered orally for 14 days, and paracetamol was administered once on day 8. The evaluated parameters included body weight, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, and liver histopathology. Paracetamol intoxication caused significant weight loss and increased AST and ALT levels (P < 0.0001). Results: All EALM doses significantly attenuated paracetamol-induced enzyme elevations. Histopathological analysis revealed severe injury, including pyknosis, in the paracetamol group, whereas EALM-treated livers maintained near-normal morphology. Among the tested doses, 200 mg/kg BW showed the most pronounced protective effect. Conclusions: These findings indicate that EALM has significant hepatoprotective activity against paracetamol-induced hepatotoxicity.
- 14 June 2026
- Published by Brieflands in Iranian Journal of Pharmaceutical Research
- Vol. 25 (1) , e171722
Open AccessHepatoprotective Effects of Ethyl Acetate Extract of Lygodium microphyllum Leaves
Background: Lygodium microphyllum is traditionally used in Chinese medicine as a decoction to treat hepatitis. Objectives: This study evaluated the in vivo hepatoprotective efficacy and optimal dose of the ethyl acetate extract of L. microphyllum leaves (EALM) against paracetamol-induced liver injury. Methods: A pilot experiment was conducted in 24 male Wistar rats divided into six groups: a normal control group, a paracetamol control group (3 g/kg body weight [BW]), and three EALM groups (200, 400, and 600 mg/kg BW). EALM was administered orally for 14 days, and paracetamol was administered once on day 8. The evaluated parameters included body weight, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, and liver histopathology. Paracetamol intoxication caused significant weight loss and increased AST and ALT levels (P < 0.0001). Results: All EALM doses significantly attenuated paracetamol-induced enzyme elevations. Histopathological analysis revealed severe injury, including pyknosis, in the paracetamol group, whereas EALM-treated livers maintained near-normal morphology. Among the tested doses, 200 mg/kg BW showed the most pronounced protective effect. Conclusions: These findings indicate that EALM has significant hepatoprotective activity against paracetamol-induced hepatotoxicity.
- Open Access
Kratom (Mitragyna speciosa) as a Phytochemical-Based Natural Product Exhibiting Opioid-like Analgesic Effects with Reduced Tolerance and Dependence Liability via TLR4-Associated Neuroimmune Modulation
Kratom (Mitragyna speciosa) is a botanical candidate for pain management with potentially reduced opioid-related risks, partly through modulation of neuroimmune pathways involving Toll-Like Receptor 4 (TLR4). This study aimed to characterize the phytochemical profile of kratom ethanol extract and evaluate its effects on TLR4 signalling, neuroinflammatory cytokines, analgesic activity, withdrawal behaviours, and organ safety in morphine-dependent mice. Metabolite profiling was conducted using UHPLC–Q-Exactive Orbitrap HRMS, followed by molecular docking of major constituents to the TLR4 complex. In vivo assessments included flow cytometry and gene expression analyses of TLR4-mediated cytokines (NF-κB, IL-1β, IL-6), behavioural assays for antinociception, endurance, and withdrawal symptoms, and histopathological and biochemical evaluation of liver, kidney, and spleen tissues. More than 100 metabolites were identified, including mitragynine and flavonoids such as rutin and isoquercetin, which showed interactions with key TLR4 residues. Selected fractions suppressed pro-inflammatory cytokine expression, increased tail-pinch latency comparable to morphine, reduced withdrawal manifestations, and demonstrated nephroprotective and immunomodulatory effects, although mild reversible hepatic alterations were observed in specific fractions. Overall, kratom ethanol extract exhibited fraction-dependent analgesic and anti-neuroinflammatory activities associated with TLR4 modulation, supporting its potential as a botanical analgesic candidate while emphasizing the importance of safety optimization and standardized fraction development.
Open AccessKratom (Mitragyna speciosa) as a Phytochemical-Based Natural Product Exhibiting Opioid-like Analgesic Effects with Reduced Tolerance and Dependence Liability via TLR4-Associated Neuroimmune Modulation
Kratom (Mitragyna speciosa) is a botanical candidate for pain management with potentially reduced opioid-related risks, partly through modulation of neuroimmune pathways involving Toll-Like Receptor 4 (TLR4). This study aimed to characterize the phytochemical profile of kratom ethanol extract and evaluate its effects on TLR4 signalling, neuroinflammatory cytokines, analgesic activity, withdrawal behaviours, and organ safety in morphine-dependent mice. Metabolite profiling was conducted using UHPLC–Q-Exactive Orbitrap HRMS, followed by molecular docking of major constituents to the TLR4 complex. In vivo assessments included flow cytometry and gene expression analyses of TLR4-mediated cytokines (NF-κB, IL-1β, IL-6), behavioural assays for antinociception, endurance, and withdrawal symptoms, and histopathological and biochemical evaluation of liver, kidney, and spleen tissues. More than 100 metabolites were identified, including mitragynine and flavonoids such as rutin and isoquercetin, which showed interactions with key TLR4 residues. Selected fractions suppressed pro-inflammatory cytokine expression, increased tail-pinch latency comparable to morphine, reduced withdrawal manifestations, and demonstrated nephroprotective and immunomodulatory effects, although mild reversible hepatic alterations were observed in specific fractions. Overall, kratom ethanol extract exhibited fraction-dependent analgesic and anti-neuroinflammatory activities associated with TLR4 modulation, supporting its potential as a botanical analgesic candidate while emphasizing the importance of safety optimization and standardized fraction development.
- Open Access
- 1 January 2025
- Published by Taylor & Francis in Stem Cells and Cloning: Advances and Applications
- Vol. ume 18, 1-13
Alginate-Based Hydrogels with Amniotic Membrane Stem Cells for Wound Dressing Application
Objective: Chronic wounds are a common clinical problem that necessitate the exploration of novel regenerative therapies. We report a method to investigate the in vitro wound healing capacity of an innovative biomaterial, which is based on amniotic membrane-derived stem cells (AMSCs) embedded in an alginate hydrogel matrix. The aim of this study was to prepare an sodium alginate-based hydrogel, cross-linked calcium chloride (CaCl2) with the active ingredient AMSC (AMSC/Alg-H) and to evaluate its in vitro effectiveness for wound closure. Methods: This hydrogel preparation involved combining sterile solutions of AMSC, sodium alginate, and CaCl2, followed by rinsing with serum-free media. The cells were cultured in different 6-well plates, namely sodium alginate, calcium chloride, AMSC, Alg-H, and AMSC/Alg-H, in complete medium with 10% FBS. The hydrogel was successfully formulated, as confirmed by characterization techniques including Scanning Electron Microscopy (SEM), Fourier Transform Infrared (FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), Cytotoxicity Studies, TGF-β 1 Level Measurement by ELISA, and Cell Scratch Wound Assay. Results: Cryo-EM characterization of the Alg-H preparation successfully demonstrated the encapsulation of MSCs. FTIR and DSC analyses indicate that crosslinking transpires in Alg-H encapsulating AMSC. The AMSC/Alg-H preparation showed no significant difference in toxicity compared to HaCaT cells (p < 0.05), indicating it was not toxic to HaCaT cells. Furthermore, in the scratch wound assay test at 24 hours, the AMSC/Alg-H preparation achieved 100% wound closure, outperforming both AMSC and Alg-H alone. In vitro assessment revealed that AMSC/Alg-H significantly enhanced key wound healing processes, including cell proliferation and migration, compared to Alg-H. Conclusion: Our study demonstrated the promising potential of AMSC/Alg-H as an enhanced regenerative therapy for in vitro wound healing. AMSC/Alg-H was able to maintain the viability of AMSCs and facilitate the formation of tissue-like structures.
- 1 January 2025
- Published by Taylor & Francis in Stem Cells and Cloning: Advances and Applications
- Vol. ume 18, 1-13
Open AccessAlginate-Based Hydrogels with Amniotic Membrane Stem Cells for Wound Dressing Application
Objective: Chronic wounds are a common clinical problem that necessitate the exploration of novel regenerative therapies. We report a method to investigate the in vitro wound healing capacity of an innovative biomaterial, which is based on amniotic membrane-derived stem cells (AMSCs) embedded in an alginate hydrogel matrix. The aim of this study was to prepare an sodium alginate-based hydrogel, cross-linked calcium chloride (CaCl2) with the active ingredient AMSC (AMSC/Alg-H) and to evaluate its in vitro effectiveness for wound closure. Methods: This hydrogel preparation involved combining sterile solutions of AMSC, sodium alginate, and CaCl2, followed by rinsing with serum-free media. The cells were cultured in different 6-well plates, namely sodium alginate, calcium chloride, AMSC, Alg-H, and AMSC/Alg-H, in complete medium with 10% FBS. The hydrogel was successfully formulated, as confirmed by characterization techniques including Scanning Electron Microscopy (SEM), Fourier Transform Infrared (FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), Cytotoxicity Studies, TGF-β 1 Level Measurement by ELISA, and Cell Scratch Wound Assay. Results: Cryo-EM characterization of the Alg-H preparation successfully demonstrated the encapsulation of MSCs. FTIR and DSC analyses indicate that crosslinking transpires in Alg-H encapsulating AMSC. The AMSC/Alg-H preparation showed no significant difference in toxicity compared to HaCaT cells (p < 0.05), indicating it was not toxic to HaCaT cells. Furthermore, in the scratch wound assay test at 24 hours, the AMSC/Alg-H preparation achieved 100% wound closure, outperforming both AMSC and Alg-H alone. In vitro assessment revealed that AMSC/Alg-H significantly enhanced key wound healing processes, including cell proliferation and migration, compared to Alg-H. Conclusion: Our study demonstrated the promising potential of AMSC/Alg-H as an enhanced regenerative therapy for in vitro wound healing. AMSC/Alg-H was able to maintain the viability of AMSCs and facilitate the formation of tissue-like structures.
- Open Access
- 1 October 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 4723-4748
Updating the Pharmacological Effects of α-Mangostin Compound and Unraveling Its Mechanism of Action: A Computational Study Review
α-Mangostin, initially identified in 1855, is a xanthone derivative compound predominantly located in the pericarp of the mangosteen fruit (Garcinia mangostana L). This compound is known for its beneficial properties as an antioxidant and anti-inflammatory agent, still holding promise for potential benefits in other related pathologies. In the investigative process, computational studies have proven highly valuable in providing evidence and initial screening before progressing to preclinical and clinical studies. This review aims to present the pharmacological findings and mechanisms of action of α-mangostin based on computational studies. The compilation of this review is founded on the analysis of relevant articles obtained from PubMed, Scopus, and ScienceDirect databases. The study commences with an elucidation of the physicochemical characteristics, drug-likeness, pharmacokinetics, and toxicity profile of α-mangostin, which demonstrates that α-mangostin complies with the Lipinski’s Rule of Five, exhibits favorable profiles of absorption, distribution, metabolism, and excretion, and presents low toxicity. Subsequent investigations have revealed that computational studies employing various software tools including ArgusLab, AutoDock, AutoDock Vina, Glide, HEX, and MOE, have been pivotal to comprehend the pharmacology of α-mangostin. Beyond its well established roles as an antioxidant and anti-inflammatory agent, α-mangostin is now recognized for its pharmacological effects in Alzheimer’s disease, diabetes, cancer, chronic kidney disease, chronic periodontitis, infectious diseases, and rheumatoid arthritis. Moreover, α-mangostin is projected to have applications in pain management and as a potent mosquito larvicide. All of these findings are based on the attainment of adequate binding affinity to specific target receptors associated with each respective pathological condition. Consequently, it is anticipated that these findings will serve as a foundation for future scientific endeavours, encompassing both in vitro and in vivo studies, as well as clinical investigations, to better understand the pharmacological effects of α-mangostin.
- 1 October 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 4723-4748
Open AccessUpdating the Pharmacological Effects of α-Mangostin Compound and Unraveling Its Mechanism of Action: A Computational Study Review
α-Mangostin, initially identified in 1855, is a xanthone derivative compound predominantly located in the pericarp of the mangosteen fruit (Garcinia mangostana L). This compound is known for its beneficial properties as an antioxidant and anti-inflammatory agent, still holding promise for potential benefits in other related pathologies. In the investigative process, computational studies have proven highly valuable in providing evidence and initial screening before progressing to preclinical and clinical studies. This review aims to present the pharmacological findings and mechanisms of action of α-mangostin based on computational studies. The compilation of this review is founded on the analysis of relevant articles obtained from PubMed, Scopus, and ScienceDirect databases. The study commences with an elucidation of the physicochemical characteristics, drug-likeness, pharmacokinetics, and toxicity profile of α-mangostin, which demonstrates that α-mangostin complies with the Lipinski’s Rule of Five, exhibits favorable profiles of absorption, distribution, metabolism, and excretion, and presents low toxicity. Subsequent investigations have revealed that computational studies employing various software tools including ArgusLab, AutoDock, AutoDock Vina, Glide, HEX, and MOE, have been pivotal to comprehend the pharmacology of α-mangostin. Beyond its well established roles as an antioxidant and anti-inflammatory agent, α-mangostin is now recognized for its pharmacological effects in Alzheimer’s disease, diabetes, cancer, chronic kidney disease, chronic periodontitis, infectious diseases, and rheumatoid arthritis. Moreover, α-mangostin is projected to have applications in pain management and as a potent mosquito larvicide. All of these findings are based on the attainment of adequate binding affinity to specific target receptors associated with each respective pathological condition. Consequently, it is anticipated that these findings will serve as a foundation for future scientific endeavours, encompassing both in vitro and in vivo studies, as well as clinical investigations, to better understand the pharmacological effects of α-mangostin.
- Open Access
- 8 August 2024
- Published by Program Studi Farmasi STIKES Mandala Waluya in Jurnal Mandala Pharmacon Indonesia
- Vol. 10 (1) , 61-67
Kajian Literatur: Aktivitas Anti-Inflamasi, Antibakteri, Dan Antioksidan Dari Tanaman Genus Piper Spesies Sirih Merah (Piper Crocatum), Dan Sirih Hijau (Piper Betle L.)
Di Indonesia banyak sekali tumbuhan sirih yang dapat kita temukan, pembudidayaan tanaman sirih tidak terlalu rumit, akan tetapi penggunaan daun sirih belum terlalu dimaksimalkan. Tanaman sirih mengandung metabolit sekunder seperti alkaloid, flavonoid, tanin, saponin, dan minyak atsiri. Metabolit tersebut diduga memiliki aktivitas sebagai anti-inflamasi, antibakteri, dan antioksidan. Metode penelitian yang dilakukan adalah metode kajian literatur dengan mengumpulkan literatur mengenai aktivitas anti-inflamasi, antibakteri dan antioksidan dari tanaman sirih merah dan sirih hijau. Hasil yang diperoleh sirih merah dan sirih hijau memiliki aktivitas anti-inflamasi, antibakteri dan antioksidan; sirih hijau menunjukkan aktivitas anti-inflamasi yang paling baik sebesar 64,53%; aktivitas antibakteri yang paling baik pada bakteri gram positif sebesar 15,031 mm dan bakteri gram negatif sebesar 16,01 mm dan aktivitas antioksidan sebesar 2,0375 ppm. Sirih merah menunjukkan aktivitas anti-inflamasi yang paling baik sebesar 21%; aktivitas antibakteri yang paling baik pada bakteri gram positif sebesar 5,7 mm dan pada bakteri gram negatif sebesar 8,74 mm dan aktivitas antioksidan sebesar 47,45 ppm.
- 8 August 2024
- Published by Program Studi Farmasi STIKES Mandala Waluya in Jurnal Mandala Pharmacon Indonesia
- Vol. 10 (1) , 61-67
Open AccessKajian Literatur: Aktivitas Anti-Inflamasi, Antibakteri, Dan Antioksidan Dari Tanaman Genus Piper Spesies Sirih Merah (Piper Crocatum), Dan Sirih Hijau (Piper Betle L.)
Di Indonesia banyak sekali tumbuhan sirih yang dapat kita temukan, pembudidayaan tanaman sirih tidak terlalu rumit, akan tetapi penggunaan daun sirih belum terlalu dimaksimalkan. Tanaman sirih mengandung metabolit sekunder seperti alkaloid, flavonoid, tanin, saponin, dan minyak atsiri. Metabolit tersebut diduga memiliki aktivitas sebagai anti-inflamasi, antibakteri, dan antioksidan. Metode penelitian yang dilakukan adalah metode kajian literatur dengan mengumpulkan literatur mengenai aktivitas anti-inflamasi, antibakteri dan antioksidan dari tanaman sirih merah dan sirih hijau. Hasil yang diperoleh sirih merah dan sirih hijau memiliki aktivitas anti-inflamasi, antibakteri dan antioksidan; sirih hijau menunjukkan aktivitas anti-inflamasi yang paling baik sebesar 64,53%; aktivitas antibakteri yang paling baik pada bakteri gram positif sebesar 15,031 mm dan bakteri gram negatif sebesar 16,01 mm dan aktivitas antioksidan sebesar 2,0375 ppm. Sirih merah menunjukkan aktivitas anti-inflamasi yang paling baik sebesar 21%; aktivitas antibakteri yang paling baik pada bakteri gram positif sebesar 5,7 mm dan pada bakteri gram negatif sebesar 8,74 mm dan aktivitas antioksidan sebesar 47,45 ppm.
- Open Access
- 1 May 2024
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 5021-5044
Chitosan/Alginate-Based Nanoparticles for Antibacterial Agents Delivery
Nanoparticle systems integrating alginate and chitosan emerge as a promising avenue to tackle challenges in leveraging the potency of pharmacological active agents. Owing to their intrinsic properties as polysaccharides, alginate and chitosan, exhibit remarkable biocompatibility, rendering them conducive to bodily integration. By downsizing drug particles to the nano-scale, the system enhances drug solubility in aqueous environments by augmenting surface area. Additionally, the system orchestrates extended drug release kinetics, aligning well with the exigencies of chronic drug release requisite for antibacterial therapeutics. A thorough scrutiny of existing literature underscores a wealth of evidence supporting the utilization of the alginate-chitosan nanoparticle system for antibacterial agent delivery. Literature reviews present abundant evidence of the utilization of nanoparticle systems based on a combination of alginate and chitosan for antibacterial agent delivery. Various experiments demonstrate enhanced antibacterial efficacy, including an increase in the inhibitory zone diameter, improvement in the minimum inhibitory concentration, and an enhancement in the bacterial reduction rate. This enhancement in efficacy occurs due to mechanisms involving increased solubility resulting from particle size reduction, prolonged release effects, and enhanced selectivity towards bacterial cell walls, stemming from ionic interactions between positively charged particles and teichoic acid on bacterial cell walls. However, clinical studies remain limited, and there are currently no marketed antibacterial drugs utilizing this system. Hence, expediting clinical efficacy validation is crucial to maximize its benefits promptly.
- 1 May 2024
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 5021-5044
Open AccessChitosan/Alginate-Based Nanoparticles for Antibacterial Agents Delivery
Nanoparticle systems integrating alginate and chitosan emerge as a promising avenue to tackle challenges in leveraging the potency of pharmacological active agents. Owing to their intrinsic properties as polysaccharides, alginate and chitosan, exhibit remarkable biocompatibility, rendering them conducive to bodily integration. By downsizing drug particles to the nano-scale, the system enhances drug solubility in aqueous environments by augmenting surface area. Additionally, the system orchestrates extended drug release kinetics, aligning well with the exigencies of chronic drug release requisite for antibacterial therapeutics. A thorough scrutiny of existing literature underscores a wealth of evidence supporting the utilization of the alginate-chitosan nanoparticle system for antibacterial agent delivery. Literature reviews present abundant evidence of the utilization of nanoparticle systems based on a combination of alginate and chitosan for antibacterial agent delivery. Various experiments demonstrate enhanced antibacterial efficacy, including an increase in the inhibitory zone diameter, improvement in the minimum inhibitory concentration, and an enhancement in the bacterial reduction rate. This enhancement in efficacy occurs due to mechanisms involving increased solubility resulting from particle size reduction, prolonged release effects, and enhanced selectivity towards bacterial cell walls, stemming from ionic interactions between positively charged particles and teichoic acid on bacterial cell walls. However, clinical studies remain limited, and there are currently no marketed antibacterial drugs utilizing this system. Hence, expediting clinical efficacy validation is crucial to maximize its benefits promptly.
- Open Access
- 1 January 2024
- Published by Wiley in Dermatology Research and Practice
- Vol. 2024 (1) , 5551774
A Comprehensive Review of the Strategies to Reduce Retinoid‐Induced Skin Irritation in Topical Formulation
Currently, retinoids are known for their abundant benefits to skin health, ranging from reducing signs of aging and decreasing hyperpigmentation to treating acne. However, it cannot be denied that there are various side effects associated with the use of retinoids on the skin, one of which is irritation. Several approaches can be employed to minimize the irritation caused by retinoids. This review article discusses topical retinoid formulation technology strategies to reduce skin irritation effects. The methodology used in this study is a literature review of 21 reference journals. The sources used in compiling this review are from PubMed, Scopus, ScienceDirect, and MEDLINE. The findings obtained indicate that the following methods can be used to lessen retinoid‐induced irritation in topical formulations: developing drug delivery systems in the formulation, such as encapsulating retinoids, transforming retinoids into nanoparticles, forming complexes (e.g., with cyclodextrin), and binding retinoids with carriers (e.g., polymers, NLC, SLN), adding ingredients with anti‐irritation activity, skin barrier improvement, and increased skin hydration to retinoid formulations (e.g., combinations of glucosamine, trehalose, ectoine, sucralfate, omega‐9, and 4‐t‐butylcyclohexanol, addition of ethanolic bark extract of Alstonia scholaris R. Br).
- 1 January 2024
- Published by Wiley in Dermatology Research and Practice
- Vol. 2024 (1) , 5551774
Open AccessA Comprehensive Review of the Strategies to Reduce Retinoid‐Induced Skin Irritation in Topical Formulation
Currently, retinoids are known for their abundant benefits to skin health, ranging from reducing signs of aging and decreasing hyperpigmentation to treating acne. However, it cannot be denied that there are various side effects associated with the use of retinoids on the skin, one of which is irritation. Several approaches can be employed to minimize the irritation caused by retinoids. This review article discusses topical retinoid formulation technology strategies to reduce skin irritation effects. The methodology used in this study is a literature review of 21 reference journals. The sources used in compiling this review are from PubMed, Scopus, ScienceDirect, and MEDLINE. The findings obtained indicate that the following methods can be used to lessen retinoid‐induced irritation in topical formulations: developing drug delivery systems in the formulation, such as encapsulating retinoids, transforming retinoids into nanoparticles, forming complexes (e.g., with cyclodextrin), and binding retinoids with carriers (e.g., polymers, NLC, SLN), adding ingredients with anti‐irritation activity, skin barrier improvement, and increased skin hydration to retinoid formulations (e.g., combinations of glucosamine, trehalose, ectoine, sucralfate, omega‐9, and 4‐t‐butylcyclohexanol, addition of ethanolic bark extract of Alstonia scholaris R. Br).